These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 23472056)
1. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. Carrara VI; Lwin KM; Phyo AP; Ashley E; Wiladphaingern J; Sriprawat K; Rijken M; Boel M; McGready R; Proux S; Chu C; Singhasivanon P; White N; Nosten F PLoS Med; 2013; 10(3):e1001398. PubMed ID: 23472056 [TBL] [Abstract][Full Text] [Related]
2. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity. Na-Bangchang K; Muhamad P; Ruaengweerayut R; Chaijaroenkul W; Karbwang J Malar J; 2013 Jul; 12():263. PubMed ID: 23898808 [TBL] [Abstract][Full Text] [Related]
3. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. Carrara VI; Sirilak S; Thonglairuam J; Rojanawatsirivet C; Proux S; Gilbos V; Brockman A; Ashley EA; McGready R; Krudsood S; Leemingsawat S; Looareesuwan S; Singhasivanon P; White N; Nosten F PLoS Med; 2006 Jun; 3(6):e183. PubMed ID: 16719547 [TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border. Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963 [TBL] [Abstract][Full Text] [Related]
5. Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors. Phyo AP; Ashley EA; Anderson TJC; Bozdech Z; Carrara VI; Sriprawat K; Nair S; White MM; Dziekan J; Ling C; Proux S; Konghahong K; Jeeyapant A; Woodrow CJ; Imwong M; McGready R; Lwin KM; Day NPJ; White NJ; Nosten F Clin Infect Dis; 2016 Sep; 63(6):784-791. PubMed ID: 27313266 [TBL] [Abstract][Full Text] [Related]
6. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border. Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919 [TBL] [Abstract][Full Text] [Related]
7. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F; van Vugt M; Price R; Luxemburger C; Thway KL; Brockman A; McGready R; ter Kuile F; Looareesuwan S; White NJ Lancet; 2000 Jul; 356(9226):297-302. PubMed ID: 11071185 [TBL] [Abstract][Full Text] [Related]
8. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border. Na-Bangchang K; Ruengweerayut R; Mahamad P; Ruengweerayut K; Chaijaroenkul W Malar J; 2010 Oct; 9():273. PubMed ID: 20929590 [TBL] [Abstract][Full Text] [Related]
9. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia. Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S Malar J; 2012 Aug; 11():300. PubMed ID: 22929621 [TBL] [Abstract][Full Text] [Related]
10. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. Carrara VI; Zwang J; Ashley EA; Price RN; Stepniewska K; Barends M; Brockman A; Anderson T; McGready R; Phaiphun L; Proux S; van Vugt M; Hutagalung R; Lwin KM; Phyo AP; Preechapornkul P; Imwong M; Pukrittayakamee S; Singhasivanon P; White NJ; Nosten F PLoS One; 2009; 4(2):e4551. PubMed ID: 19234601 [TBL] [Abstract][Full Text] [Related]
11. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Wongsrichanalai C; Sirichaisinthop J; Karwacki JJ; Congpuong K; Miller RS; Pang L; Thimasarn K Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):41-9. PubMed ID: 11485094 [TBL] [Abstract][Full Text] [Related]
12. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F Malar J; 2009 Jan; 8():11. PubMed ID: 19138391 [TBL] [Abstract][Full Text] [Related]
13. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850 [TBL] [Abstract][Full Text] [Related]
14. Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border. Rojanawatsirivet C; Congpuong K; Vijaykadga S; Thongphua S; Thongsri K; Bangchang KN; Wilairatana P; Wernsdorfer WH Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):560-5. PubMed ID: 15689066 [TBL] [Abstract][Full Text] [Related]
15. Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003. Suwandittakul N; Chaijaroenkul W; Harnyuttanakorn P; Mungthin M; Na Bangchang K Korean J Parasitol; 2009 Jun; 47(2):139-44. PubMed ID: 19488420 [TBL] [Abstract][Full Text] [Related]
16. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients. Lee SJ; Ter Kuile FO; Price RN; Luxemburger C; Nosten F PLoS One; 2017; 12(2):e0168780. PubMed ID: 28192434 [TBL] [Abstract][Full Text] [Related]
17. Molecular surveillance of artemisinin resistance falciparum malaria among migrant goldmine workers in Myanmar. Nyunt MH; Wang B; Aye KM; Aye KH; Han JH; Lee SK; Han KT; Htut Y; Han ET Malar J; 2017 Mar; 16(1):97. PubMed ID: 28249583 [TBL] [Abstract][Full Text] [Related]
18. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010. Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833 [TBL] [Abstract][Full Text] [Related]
19. Novel Cross-Border Approaches to Optimise Identification of Asymptomatic and Artemisinin-Resistant Plasmodium Infection in Mobile Populations Crossing Cambodian Borders. Edwards HM; Canavati SE; Rang C; Ly P; Sovannaroth S; Canier L; Khim N; Menard D; Ashton RA; Meek SR; Roca-Feltrer A PLoS One; 2015; 10(9):e0124300. PubMed ID: 26352262 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border. Hoglund RM; Ruengweerayut R; Na-Bangchang K Malar J; 2018 Sep; 17(1):322. PubMed ID: 30176888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]